Lonza
John Pietruszka is a seasoned executive in the quality management field with extensive experience in biologics and pharmaceutical industries. Currently serving as the Global Head of Quality for Biologics at Lonza since September 2023, John previously held senior leadership roles including SVP, Head of Global Quality Management at Bayer and VP, Global Head of Strategy & Program Management at GSK. John’s career spans various key positions at industry leaders such as Novartis Vaccines and Diagnostics and GlaxoSmithKline, where responsibilities included overseeing quality operations, validation programs, and new product introductions. John holds a Bachelor of Science in Chemical Engineering from the University of Pittsburgh and completed the Executive Development Program at The Wharton School.
This person is not in any offices
Lonza
66 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.